[LGND] YoY Quarter Result on 31-Dec-2013 [#Q4]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
24-Feb-2014
Financial Year
2013
Quarter
31-Dec-2013 [#Q4]
Profit Trend
QoQ- -4.89%
YoY- 75.82%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 38,185 21,192 22,998 14,737 13,635 12,936 3,940 45.96%
PBT 7,230 5,826 7,012 2,008 950 5,997 -1,587 -
Tax 10,355 -515 279 139 -1,636 495 -3,935 -
NP -3,125 6,341 7,055 1,869 1,063 5,502 4,503 -
Tax Rate -143.22% 8.84% -3.98% -6.92% 172.21% -8.25% - -
Total Cost 41,310 14,851 15,943 12,868 12,572 7,434 -563 -
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin -8.18 29.92 30.68 12.68 7.80 42.53 114.29 -
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
EPS -0.15 0.32 0.35 0.09 0.05 0.28 0.23 -
EPS Diluted -0.15 0.29 0.34 0.09 0.05 0.28 0.23 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.